Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease
- PMID: 1355334
- DOI: 10.1002/ana.410310608
Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease
Abstract
Neurotransmitter markers for acetylcholine, serotonin (5-HT), and dopamine (DA) were measured in autopsied human nucleus basalis of Meynert (nbM) from nondemented individuals without heart disease (non-HD) (age range, 4-84 years; n = 77), nondemented individuals with heart disease (HD) (age range, 57-92 years; n = 23), and individuals with Alzheimer's disease (AD) (age range, 59-92 years; n = 22). No significant differences in any chemical marker were found between age-matched HD and non-HD individuals. The activities of choline acetyltransferase (ChAT) and acetylcholinesterase (AChE), and [3H]spiperone binding were regionally distributed within the nbM in control (non-HD) subjects less than 54 years of age. The activity of AChE, 5-[3H]HT binding, and the content of homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA), and 5-HT were regionally distributed in the nbM in non-HD, HD, and AD subjects more than 54 years of age. The binding of [3H]spiperone was regionally distributed in the nbM in HD and AD subjects more than 54 years of age, only. Activity of ChAT and AChE, content of 5-HT, 5-HIAA, and DA, binding of 5-[3H]HT, and the turnover number for DA (ratio of HVA/DA) all decreased with increasing age in the non-HD control population. The content of HVA, binding of [3H]spiperone, and the turnover number for 5-HT (ratio of 5-HIAA/5-HT) did not change with increasing age. Significant reductions in ChAT and AChE activities were found in AD nbM compared with postmortem interval- and age-matched HD and non-HD individuals. The reduction of 5-HT and 5-HIAA content and [3H]spiperone binding in individuals with AD of all ages suggests a loss of functional serotonergic innervation of the nbM. Dopaminergic synaptic markers were less affected in AD nbM, although turnover numbers for both DA and 5-HT were increased in AD. Receptor upregulation in response to presynaptic deficits did not occur for DA or 5-HT.
Similar articles
-
Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease.J Comp Neurol. 1999 Sep 6;411(4):693-704. J Comp Neurol. 1999. PMID: 10421878 Clinical Trial.
-
Galanin immunoreactivity is increased in the nucleus basalis of Meynert in Alzheimer's disease.Ann Neurol. 1990 Aug;28(2):157-61. doi: 10.1002/ana.410280207. Ann Neurol. 1990. PMID: 1699471
-
Alzheimer's disease: monoamines and spiperone binding reduced in nucleus basalis.Ann Neurol. 1986 Jun;19(6):602-4. doi: 10.1002/ana.410190616. Ann Neurol. 1986. PMID: 2425718
-
Molecular forms of acetylcholinesterases in Alzheimer's disease.Fed Proc. 1986 Dec;45(13):2982-8. Fed Proc. 1986. PMID: 2430839 Review.
-
[Neuropathology of Alzheimer's disease and mild cognitive impairment].Rev Neurol. 2003 Jul 16-31;37(2):155-63. Rev Neurol. 2003. PMID: 12938076 Review. Spanish.
Cited by
-
NMDA-induced glutamate and aspartate release from rat cortical pyramidal neurones: evidence for modulation by a 5-HT1A antagonist.Br J Pharmacol. 1995 Aug;115(7):1169-74. doi: 10.1111/j.1476-5381.1995.tb15020.x. Br J Pharmacol. 1995. PMID: 7582540 Free PMC article.
-
Basal forebrain cholinergic system volume is associated with general cognitive ability in the elderly.Neuropsychologia. 2018 Oct;119:145-156. doi: 10.1016/j.neuropsychologia.2018.08.005. Epub 2018 Aug 7. Neuropsychologia. 2018. PMID: 30096414 Free PMC article.
-
Effects of Ncl. Basalis Meynert volume on the Trail-Making-Test are restricted to the left hemisphere.Brain Behav. 2015 Dec 29;6(1):e00421. doi: 10.1002/brb3.421. eCollection 2016 Jan. Brain Behav. 2015. PMID: 27110442 Free PMC article.
-
Limited effects of an eIF2αS51A allele on neurological impairments in the 5xFAD mouse model of Alzheimer's disease.Neural Plast. 2015;2015:825157. doi: 10.1155/2015/825157. Epub 2015 Mar 26. Neural Plast. 2015. PMID: 25883808 Free PMC article.
-
Functional and neurobiological similarities of aging in monkeys and humans.Age (Omaha). 1997 Jan;20(1):29-44. doi: 10.1007/s11357-997-0003-3. Age (Omaha). 1997. PMID: 23604289 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical